Biotechnology Drugs Putting Pressure On Insurance Premiums

The specialty drugs seem to be putting pressure on insurance premiums. These drugs which are being used for treating rare diseases is building pressure on the health insurance and is making it costly for everybody. In some of the cases the cost of the treatment can touch up to $200,000 a year. These drugs are posing a challenge to every health plan in the U.S. These specialty drugs are administered in case of rare diseases and are quite costly. It has been found out that these drugs comprise around nineteen percent or $40 billion of the pharmaceutical spending and it is expected that the figures would cross $90 billion by 2009. Health insurers are promoting generic drugs but government regulators seem to be averse to the idea of generic drugs and at the end it is the patients who are left to suffer.